Results 221 to 230 of about 52,668 (245)
Some of the next articles are maybe not open access.
Journal of Environmental Microbiology and Toxicology, 2020
Community and hospital acquired infections caused by drug resistant organisms especially the extended spectrum β-lactamase producers among members of the family Enterobacteriaceae have been on a global increase. Such infections could lead to an increased healthcare costs, morbidity and mortality.
Lawal Garba +5 more
openaire +1 more source
Community and hospital acquired infections caused by drug resistant organisms especially the extended spectrum β-lactamase producers among members of the family Enterobacteriaceae have been on a global increase. Such infections could lead to an increased healthcare costs, morbidity and mortality.
Lawal Garba +5 more
openaire +1 more source
Journal of Biochemistry, Microbiology and Biotechnology, 2018
Extended spectrum beta lactamases (ESβLs) are enzymes which have evolved from bacteria upon exposure to penicillins antibiotics. Such bacteria have developed resistance to Beta lactam antibiotics and their relatives such as cephalosporins (extended spectrum beta lactam antibiotics).
L. Garba +6 more
openaire +1 more source
Extended spectrum beta lactamases (ESβLs) are enzymes which have evolved from bacteria upon exposure to penicillins antibiotics. Such bacteria have developed resistance to Beta lactam antibiotics and their relatives such as cephalosporins (extended spectrum beta lactam antibiotics).
L. Garba +6 more
openaire +1 more source
OHIO-1 β-lactamase resistant to mechanism-based inactivators
FEMS Microbiology Letters, 1992Robert A Bonomo +2 more
openaire +1 more source
Fluorogenic Probes/Inhibitors of β‐Lactamase and their Applications in Drug‐Resistant Bacteria
Angewandte Chemie - International Edition, 2021Qiong Wu, Xiamin Cheng, Lin Li
exaly
A β-lactamase belonging to group 2e from oral clinical isolates of Prevotella intermedia
FEMS Microbiology Letters, 1998openaire +1 more source
New β-Lactam–β-Lactamase Inhibitor Combinations
Clinical Microbiology Reviews, 2020Dafna Yahav +2 more
exaly
Interplay between β-lactamases and new β-lactamase inhibitors
Nature Reviews Microbiology, 2019Karen Bush, Patricia A Bradford
exaly
Epidemiology of β-Lactamase-Producing Pathogens
Clinical Microbiology Reviews, 2020Karen Bush, Patricia A Bradford
exaly
An update on β-lactamase inhibitor discovery and development
Drug Resistance Updates, 2018Jean-Denis Docquier, Stefano Mangani
exaly

